Archive →
Daily Morning Briefing

Monday, 18 May 2026

Drone strike sets fire at the UAE's Barakah nuclear plant — first time the site has been hit in the Iran war · Global bond rout deepens, JGB 10y to 2.80% (1997 high), US long bond highest since 2023 · G-7 finance ministers open in Paris today with bond volatility the unscheduled headline · China April activity badly misses — industrial output slowest since mid-2023, retail sales slowest since end-2022 · WHO declares global Ebola emergency in Congo as CDC escalates response · Andalusia delivers Spain's PSOE its worst regional result on record · Gilts and sterling under fresh pressure as hedge funds short cable on Burnham risk
Europe/Rome 06:00 · Asia open · pre-European open · Bond rout + inflation premium dominate · oil two-way · Week ahead: G-7 Paris Mon–Tue · FOMC minutes Wed · Nvidia Wed · Walmart Thu · UK CPI Wed · flash PMIs Fri

Top of the morning

Markets snapshot — Asia open / pre-European open

Cash levels reflect Friday 15 May 2026 close where Asia has not yet repriced; rates and oil reflect Monday early Asia. Read live off the Bloomberg Europe and FT homepage tickers via Control Chrome on Luca's tabs, cross-referenced with CNBC and Reuters.

InstrumentLastChange / context
S&P 500 (Fri close)7,408.50−1.24% Fri · futures soft pre-open
Nasdaq Composite (Fri close)26,225.14−1.54% Fri
Dow Jones (Fri close)49,526.17−1.07% Fri · −537 pts
FTSE 100 (Fri close)10,195.37−1.71% Fri
Nikkei 225 (Mon)~60,200~−2% intraday, JGB-led
Hang Seng (Mon, futures)~25,733below Fri close 25,962.73
Shanghai (Mon)−0.22% on China April miss
US 10y Treasury~4.63%+~4bp vs Fri · 30y highest since 2023
US 2y Treasury~4.10%curve flattening at the front
UK 30y Gilt~5.85%retesting post-1998 peak
Japan 10y JGB~2.80%+~9bp · highest since 1997
Brent crude (front-month)~$108two-way: Barakah strike bid vs demand worry
WTI (front-month)~$105two-way
Gold (XAU spot)~$4,548slight retreat · Hormuz quagmire still bid
EUR/USD~1.1623little changed on the open
GBP/USD~1.333hedge funds adding shorts on Burnham risk
USD/JPYJGB-led repricing, intervention chatter quiet
Copper (LME)extending retreat on US-Iran stalemate
Bitcoin~$82krange-bound, inflation-fear sensitive

Geopolitics & the weekend backdrop

The Barakah strike is the most consequential geopolitical event of the weekend. The drones hit only an external generator, the reactor is unaffected, and the UAE's nuclear regulator confirms normal operations — but a strike on a Gulf nuclear facility is a Rubicon in this war, even if the perpetrator stays officially unattributed. The Israeli press source frames it as a deliberate "we can reach further" signal. With US and Iran reported "far apart" on any Hormuz reopening, the structural assumption that the war would slowly de-escalate into a frozen-conflict pattern has been shaken. Saudi Arabia also intercepted three drones the same day. Gulf freight rates are climbing as shippers shift cargo to trucks — the FT's tipping-point framing on the global energy crisis (emergency oil measures now in nearly 80 countries) is becoming the operating reality, not a forecast.

Around the war perimeter the news is denser than usual. Ukraine staged a record-scale drone attack on Moscow targeting a refinery; Zelensky publicly endorses it as "entirely justified." Russia is expanding its LNG dark fleet by four more tankers. The EU's planned steel quota cut is being criticised as harming Ukraine (~€1bn). Latvia's government collapsed last week over Russia-bound drones, and Putin replaced a Russian regional governor critical of him along the Ukraine border. The Trump–Xi summit aftermath continues to be parsed: Trump briefed South Korea's Lee after the summit and the public read-outs from Washington and Beijing remain meaningfully divergent. The most useful single line for European exporters: NATO is moving to press Europe's arms makers to boost investment and production capacity, a structural demand-side signal for defence equities. Andalusia's Sunday result is now the freshest piece of European political risk in the mix.

Central banks & the rate narrative

Two days of G-7 finance ministers open in Paris today with the bond rout as the unscheduled headline. The pieces are now visibly aligning: a 10y JGB at 2.80% (highest since 1997) on a weaker 5y auction overnight, the US long bond at its highest since 2023 on inflation-via-Iran concerns and on doubts about Fed independence as Warsh takes the chair, 30y gilts near a post-1998 peak on Burnham-risk fiscal worry, German wholesale prices at a 3y high, Berlin's lifted inflation forecast for 2026. The disinflation narrative the soft-landing trade depended on is under genuine strain. The G-7 statement language is what matters most; any explicit acknowledgement of a long-end credibility premium would mark this as a regime event. The street is loud about the move — SocGen called Friday "unhinged," Yardeni publicly urged the Fed to drop its easing bias, Gundlach said it's "just not possible" for the Fed to cut. Wednesday's FOMC minutes are the first read on the policy debate before the chair transition completes; Powell is operating as Chair Pro Tempore until Warsh is sworn in. Goldman's central-bank gold-buying call adds another pillar to the inflation-hedge bid.

Outside the US the picture has not eased. The BOJ's June meeting hike case has hardened on this morning's JGB move and Friday's Japan PPI print of 4.9% y/y. Thai growth unexpectedly accelerated on Q1 spending and exports — one of the few positive Asia surprises. Indonesia's rupiah hit a record low, stocks and bonds tumbled — EM under stress. Turkey scrapped its inflation target, which is closer to credibility erosion than to a policy reset. The ECB's Stournaras flagged that a modest rate move would limit pain — language to file ahead of the 11 June meeting where oil-upside risk is now explicit. The BoE is reportedly diluting stablecoin rules under industry pressure — small but symptomatic of regulator-bandwidth strain. Cross-region: the central-bank consensus that the disinflation trade still works no longer commands the room.

Big Tech, AI & corporates — Monday positioning

The AI capital story keeps widening. Publicis's $2.2bn US data-company deal is the largest adland purchase of the cycle and another example of AI-stack rollups. The FT's lead AI story has ByteDance and Kuaishou ahead of leading Western models on video-generation quality — the first genuinely concrete tell that the GenAI race is bifurcating by domain rather than converging. Apple is shipping a ChatGPT-style Siri app whose differentiator is auto-deleting chats — a positioning move on privacy against OpenAI and Google. OpenAI is reportedly preparing legal action against Apple over the iPhone AI commercial. Big Tech borrowing for AI capex is increasingly happening outside the public bond market — feeding directly into the private-credit valuation question. ASML is partnering with Tata Electronics on India's chip plans. An obscure Japanese stock measure has widened on the global hunt for AI winners (FT). Multiverse, the AI-workforce-training company, has hit $2.1bn valuation. Recruit Holdings shares jumped most since IPO on a guidance beat; Kioxia drew heavy buy orders on AI-driven profit. Korea's AI rally is fading on the rate move.

On the corporate / deal tape: NextEra–Dominion talks at ~$400bn could land an announcement as early as today (largest US utility, AI-power demand thesis); the SpaceX IPO is reportedly filing midweek at a ~$1.75tn valuation with a structure that ensures Musk cannot be fired (investors are accepting weak governance for access). Adani settled with the SEC on the weekend, closing a multi-year US overhang on India's largest group. Bain Capital closed a $10.5bn Asia fund — its largest. HSBC paused a $4bn private-credit allocation; the FT confirms it as a credit-cycle data point. BlackRock TCP Capital remains under DOJ scrutiny on valuations. Mortgage Company of Canada has halted redemptions. Goldman is exploring private-market risk-transfer deals. Trump's Hormuz ship-insurance facility has reportedly done $0 of business — a notable null. Schroders is exiting China mutual funds. Honda–Nissan tie-up chatter revived. Berkshire trimmed Chevron by $8bn into the oil spike. McKinsey is cutting partner cash share in a post-AI pay revamp — the consultancy compensation model is starting to absorb AI productivity gains. Vodafone Idea got $500m from Birla. Starbucks will take a $400m charge as it cuts more corporate staff. Abu Dhabi is backing a $13bn US gas plant. Shein bought Everlane. A Chinese data-centre spin-off plans a dual Singapore/US IPO.

Health & science (worth a clinician's glance)

The WHO's formal declaration of a Public Health Emergency of International Concern over the DRC Ebola outbreak is the headline news. Bloomberg's "silent spread" framing — surveillance gaps mean the outbreak has been seeded further than first detected — is the operationally relevant point. The CDC has signalled it will escalate response, after a year in which US global-health-security funding was cut. The clinical profile of Ebola is unchanged; the systems-level questions — contact-tracing capacity, ring-vaccination logistics, regional preparedness funding — will determine whether this stays a containment story or grows. Patagonia's published lessons from hantavirus got a sympathetic FT writeup as the corporate-preparedness frame returns. Worth watching WHO situation reports daily through the week.

Other threads: Galderma reports the "Botox boom" continuing to defy luxury slowing — dermatology aesthetics has decoupled from broader discretionary cyclicality, which has both clinical-practice and equity implications. Bloomberg has Dexcom expanding sensors beyond diabetes into broader wellness — a structural metabolic-monitoring story; the consumer-facing CGM market may be where the closest analog of the GLP-1 cycle is now setting up. The FDA's reshuffle of senior drug and vaccine regulators will start to flow into advisory-committee composition and approval pacing through the summer; pulmonary/respiratory and vaccines are the therapeutic areas where personnel turnover matters most. EY's retraction of an AI-hallucinated study last week is the cleanest cautionary tale yet for AI-assisted clinical literature work — fabricated citations carry far higher stakes in clinical research than in consulting. Nvidia billionaire Mark Stevens's $175m gift to a new Bay Area medical school is the most visible new entry in the AI-fortunes-to-medical-philanthropy pattern.

Week ahead (CET)